Lemonaid Health Raises $33M to Expand On-Demand Consumer Telehealth Platform

What You Need to Know:

Founded in 2013 by Co-Founders Ian Van Every and Paul.
Johnson, Lemonaid Health uses clients direct access to the care they need,.
from assessment through treatment nationally throughout the U.S.
The business. leverages evidence-based guidelines and the most current scientific procedures.
to offer quality care for less than normal co-pays. In just a couple of minutes,.
patients are able to interact with a U.S.-licensed medical professional or nurse specialist.
for conditions like anxiety and depression, urinary system infections (UTIs),.
contraception, hair loss, hypothyroidism, impotence, genital herpes.
and sinus infections. Patients are also used quick and complimentary shipment of.
prescription medications through the platform to speed treatment.

Online Doctors Office & & Medicine Delivery.

Lemonaid Health,
a practical, cost effective, on-demand platform for telehealth, has raised a $33.
million Series B round of funding, bringing overall financing to $55 million. The.
oversubscribed round was led by Olive Tree.
Ventures with participation from Artis.
Ventures, Correlation Ventures, Hikma Ventures, Sierra Ventures and others.

For $25 per see, patients can request prescriptions by.
completing a questionnaire and attaching a picture for the doctor to draw up.
the prescription, and after that have it instantly sent out to a locally chosen.
drug store within a 2-hour turnaround time. The check out expense is much more affordable than a.
co-pay, and an e-mail summary of the care provided is sent out for the.
patients primary care doctor.

With the financial investment, Lemonaid Health will expand its team of.
medical professionals and increase the number of services being provided to.
patients, including treatment for asthma, high blood pressure, Type 2 diabetes and.
more psychological health services.

Lemonaid Health has seen a surge in demand for its services.
and interest from prospective partners during the COVID-19 pandemic..
at first a direct-to-consumer provider, the business is starting to deal with.
partners within the existing health care system to further expand reach.

The coronavirus pandemic has accelerated the integration of.
telehealth and transformed the method customers interact with their health care.
companies. Companies are seeing 50 to 175 times the number of clients by means of.
telehealth platforms than they were prior to the outbreak, according to a McKinsey COVID-19 Consumer Survey.

COVID-19 Driving Telehealth Adoption.

— Lemonaid Health, a direct to customer telehealth business raises $33M in Series B funding to expand the companys medical group and variety of services being used to clients

— To date, the business has actually dealt with more than a million clients.
online for a range of medical conditions varying from erectile dysfunction to sinus infections
to anxiety and stress and anxiety for approximately $25/visit (less than a common co-pay).

Expansion Plans.

” The U.S. healthcare system has actually had a hard time to deliver.
the services clients need in a method that is effective and convenient. The obstacles.
of offering regular care has actually been worsened recently as most of.
health resources have been concentrated on reacting to the coronavirus.
pandemic,” stated Paul Johnson, co-founder and CEO of Lemonaid Health.
” We founded Lemonaid Health with a vision to increase access to.
budget-friendly, premium healthcare. As more customers have actually relied on.
telehealth in the last 6 months, weve seen considerable development in need for.
our online services. With the additional funding, we will have the ability to help even.
more clients get the care they deserve and expand our services in partnership.
with other doctor.”.